News
The fact that multiple Cencora, Inc. (NYSE:COR) insiders offloaded a considerable amount of shares over the past year could have raised some eyebrows amongst investors. When analyzing insider ...
Has Cencora (COR) been one of those stocks this year? By taking a look at the stock's year-to-date performance in comparison to its Medical peers, we might be able to answer that question.
$60,000 of CENCORA INC. lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing. This included lobbying on issues like: "IRA implementation. Drug Shortages ...
Hot on the heels of announcing a further 26 cast members for the upcoming Avengers: Doomsday, Marvel and Robert Downey Jr. have teased they’re not done yet. Yesterday, Marvel announced the cast ...
Morgan Stanley analyst Erin Wright raised the firm’s price target on Cencora (COR) to $288 from $263 and keeps an Equal Weight rating on the shares. While policy will be “front and center ...
New information is emerging about 57-year-old Robert Morales, one of two people killed Thursday in a shooting on Florida State University's campus. Morales, who worked in FSU's dining services ...
Christopher T. Saunders/Paramount+ ; Robert Patrick Instagram 1923 star Robert Patrick says a recent ACL injury is the reason why his appearance on the hit Yellowstone prequel series is so ...
Cencora COR has outperformed the market over the past 10 years by 9.42% on an annualized basis producing an average annual return of 19.01%. Currently, Cencora has a market capitalization of $55. ...
Shares of Cencora Inc. COR rose 1.92% to $279.15 Thursday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index SPX falling 3.46% to 5,268.05 and ...
Citi analyst Daniel Grosslight maintained a Buy rating on Cencora (COR – Research Report) today and set a price target of $330.00. The company’s shares closed yesterday at $284.44. Discover ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results